Clinical Trial

Evaluation of the Efficacy of Addition of Progesterone to Standard Chemotherapy in Adrenocortical Carcinoma (ACC)

Study acronym: PESETA
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is a prospective randomized, double blind, placebo controlled phase II study planned in patients with advanced ACC. The study will be conducted at ASST Spedali Civili Hospital and University of Brescia in Brescia.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-06-12.
Trial Details
NCT Number NCT05913427
Lead Sponsor Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Conditions Adrenocortical Carcinoma
Enrollment 80 participants
Start Date 2022-06-08
Primary Completion 2027-06-08 (estimated)
Study Completion 2027-06-08 (estimated)
Updated on ClinicalTrials.gov 2024-08-01